1. Arcamone, F. and Penco, S. (1988) “Synthesis of New Doxorubicin Analogs” in J. W. Lown (ed.), Anthracycline and Anthracenedione-Based Anticancer Agents, Elsevier, Amsterdam, pp. 1–53.
2. Hoffman, D., Berscheid, H. G., Boettger, D., Hermentin, P., Sediacek, H. H., and Kraemer, H. P. (1990) “Structure-Activity Relationship of Anthracyclines in Vitro”, J. Med. Chem. 33, 166–171.
3. Ohe, Y., Nakagawa, K., Fojiwara, Y., Sasaki, Y., Minato, K., Bungo, M., Niimi, S., Horichi, N., Fukuda, M., and Saijo N. “In Vitro Evaluation of the New Anticancer Agents KT6149, MX-2, SM5887, Menogaril, and Libiomycin Using Cisplatin-or Adriamycin-resistant Human Cancer Cell Lines” Cancer Res. 49, 4098–4102.
4. Arcamone, F. (1989) “Oligo (N-Methylpyrrolecarboxamide) Antibiotics” in Atta-Ur-Rahman (Ed.), Studies in Natural Products Chemistry, Vol. 5, Structure Elucidation (Part B), Elsevier, Amsterdam, pp. 549–588.
5. Zimmer, Ch. and Waehnert, U. (1986) “Non Intercalating DNA Binding Ligands: Specificity of the Intercalation and Their Use as Tools in Biophysical, Biochemical and Biological Investigation of Genetic Material” Prog. Biophys. Mol. Biol. 47, 31–112.